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Abstract 
High throughput mRNA expression profiling can be used to characterize the response of cell 
culture models to perturbations such as pharmacologic modulators and genetic perturbations.  As 
profiling campaigns expand in scope, it is important to homogenize, summarize, and analyze the 
resulting data in a manner that captures significant biological signals in spite of various noise 
sources such as batch effects and stochastic variation.  We used the L1000 platform for large-
scale profiling of 978 genes, chosen to be representative of the genome as whole, across 
thousands of compound treatments.  Here, a method is described that uses deep learning 
techniques to  convert the expression changes of the landmark genes into a perturbation barcode 
that reveals important features of the underlying data, performing better than the raw data in 
revealing important biological insights.  The barcode  captures compound structure and target 
information, in addition to predicting a compound’s high throughput screening promiscuity, to a 
higher degree than the original data measurements, indicating that the approach uncovers 
underlying factors of the expression data that are otherwise entangled or masked by noise.  
Furthermore, we demonstrate that visualizations derived from the perturbation barcode can be 
used to more sensitively assign functions to unknown compounds through a guilt-by-association 
approach, which we use to predict and experimentally validate the activity of compounds on the 
MAPK pathway. The demonstrated application of deep metric learning to large-scale chemical 
genetics projects highlights the utility of this and related approaches to the extraction of insights 
and testable hypotheses from big, sometimes noisy data. 
 
Background 
Pharmacology is generally explored in a linear and iterative manner, starting from the observation of an 
activity, that is then optimized for selectivity and potency via various methods, and subsequently tested in 
preclinical and randomized controlled clinical studies for safety and efficacy.  In general, the activity of 
compounds on targets other than the intended one(s) is limited, though such ‘off-target’ activities may 
lead to adverse events.  The detection of polypharmacology is desired and could be facilitated by 
comprehensive profiling of drug candidates on a general phenotyping platform, i.e. a consistent method to 
broadly assess the phenotypic effects of compound treatment.  Such a platform could be used in order to 
uncover unexpected phenotypic signals beyond the originally identified mechanism-based phenotype. 
Phenotypic screening is considered by some to be a return to pharmacology’s roots (Swinney and 
Anthony 2011), and by others a new discipline, that will need to prove itself over the coming decades 
(Eder, Sedrani et al. 2014).  In either case, there is increased interest in applying cell-based pathway or 
phenotype screens to identify unknown/unexpected targets along with tool compounds that can be used 
for target validation, and potentially as starting points for drug discovery.  One major hurdle in 
phenotypic screening approach versus a target-based approach lies in the identification of the target(s) of 
molecules that show an activity in cell-based (or organismal) assays.  A general phenotyping platform 
could be used to infer mode of action of unknown compounds based on similarity of induced expression 
profiles’ similarity to those of annotated compounds.  Such data can also in some cases be used to 
propose new indications for known molecules (Lamb, Crawford et al. 2006).   
Lastly, a general phenotyping platform will allow one to monitor compounds through their maturation 
and optimization in order to prioritize series based on selectivity and to quickly identify potential 
polypharmacology and safety warning signals (Verbist, Klambauer et al.). 
We suggest that mRNA is an ideal analyte for a general phenotyping platform.  Whereas gene expression 
changes are often distal to signaling and metabolic pathways that drug discovery aims to modulate, most 
perturbations of such pathways eventually lead to the nucleus and to transcriptional changes that 
propagate, amplify, or compensate for the immediate effects of a perturbation.  mRNA also has the 
beneficial property that its measurement is fairly easy to generalize, such that any set of target sequences 
can be measured quantitatively and in parallel.  Thus, a potentially broadly useful general phenotyping 
platform would quantitate mRNA, be medium to high throughput, be affordable to apply to thousands of 
samples, and produce highly reproducible data. 
The L1000 platform (Peck, Crawford et al. 2006) has the potential to be just such a general phenotyping 
platform, one that can be used in various stages of drug discovery, including target identification and 
validation, hit-to-lead, lead optimization, as well as safety assessment and repurposing.  978 genes were 
selected to be representative of the expression of the remainder of the transcriptome (Duan, Flynn et al. 
2014), and the platform is used to capture the transcriptional phenotypes using this reduced set of 
‘landmark’ genes.  The high throughput and relatively low cost of the bead array based implementation 
permits comprehensive application to large numbers of perturbations, be they different compounds, 
different cellular contexts, titrations, compound series, etc. 
However, if such a platform is applied for large sets of perturbation, spanning years of different project 
stages and various programs, then data analysis, and particularly homogenization, become important.  
Large scale expression profiling projects such as the Connectivity Map (Lamb, Crawford et al. 2006) and 
applications presented herein have to contend with day-to-day variation in cellular responses.  Indeed, 
batch effects were previously considered a nuisance that was dealt with using robust rank-based statistics 
(connectivity score, (Lamb, Crawford et al. 2006)), and via use of biologically motivated data summaries 
such as Gene Set Enrichment Analysis (Mootha, Lindgren et al. 2003, Subramanian, Tamayo et al. 2005).  
It is not clear that such nonparametric approaches, which depend on prior knowledge (biological 
pathways or previous expression experiments), yield the highest possible sensitivity and specificity for 
downstream analyses. 
Herein we present a novel method of representing the expression profiles of the L1000 platform as a short 
binary barcode.  The approach starts by training a deep model that learns to distinguish replicate from 
nonreplicate profiles.  The internal state of the model thus learned demonstrated properties previously 
ascribed to deep neural network models, namely a hierarchical representation that captures the regularities 
and underlying structure of the input data  (Bengio 2012, Bengio 2013).  The internal state represents a 
robust, abstracted representation of the data, one that captures inherent aspects of the biology such as 
similarity of compound targets and pleiotropy.  We go on to apply this framework to prospectively predict 
the targets of compounds based on the transformation of their induced expression profiles.  
 Methods 
L1000 data generation 
Doses for treatment were chosen using the following hierarchy of approaches: for compounds with known 
biological activity and toxicity, the dose with the highest therapeutic window was selected.  For 
compounds with only biological activity, the EC80 was used.  For compounds without relevant cell-based 
assay activity, the highest non-toxic dose was used, up to 20µM.  Two cell lines were used: PC3 and 
ME180.  A number of compounds were profiled in both cell lines, the rest were profiled in just one of the 
two.  Most compounds were profiled as biological replicates by performing identical treatments and lysis 
on separate days, some compounds were only represented by a single instance (the latter contributed only 
to negative example pairs in the metric learning).  Compound treatment time was 6 hours, after which 
cells were lysed, frozen, and shipped to Genometry for processing.  A total of 3699 compounds were 
screened.  Compounds were selected based on being tool bioactive compounds, active compounds for 
ongoing phenotypic screening programs, and compounds of interest for particular compound optimization 
programs.  Compound profiling was performed in four independent campaigns over the course of 14 
months. 
Data processing 
Initial data processing was conducted by Genometry using a standard pipeline.  Briefly, Luminex 
intensity measurements were assessed for consistency of relative expression of control genes.  Samples 
passing well and plate level thresholds were summarized by conversion of intensity data to calculated log2 
Genechip-equivalent intensities and normalized based on control gene intensities.  Finally, the data on 
each plate was standardized based on the median and median absolute deviation of the vehicle control 
samples to calculate z-scores for each gene.  These z-scores were the input for the deep metric learning, 
and were also analyzed directly as a baseline for data interpretation. 
Deep metric learning 
A metric learning cost module that takes consecutive pairs of training examples and calculates a distance 
between them, and thereby a cost, was implemented using the Pylearn2 framework (Goodfellow, Warde-
Farley et al. 2013).  Internal data representing L1000 data as z-scores of 7573 profiles of 3699 compounds 
was used.  Train/validation/test datasets were made from the initial data by selecting respectively 80, 10, 
and 10 % of the initial 3.7k compounds.  Within a dataset, a sample of pairs of profiles representing 
biological replicates was used for positive examples (n=40k), and in addition a sample of an equal 
number of pairs of samples that were not biological replicates was used as negative examples.  
Hyperparameters (number and type of layers, regularization, dropout), were tuned manually based on 
accuracy of the model on the validation dataset, and the model depicted in Figure 2 emerged as the best 
performing.  In order to build a model that facilitates application to large scale profiling datasets, it was of 
interest to bias the model to produce a representation that could be used akin to locality sensitive hashing 
(Masci, Bronstein et al. 2014), or semantic hashing (Salakhutdinov and Hinton 2009), whereby large 
collections of profiles can be queried for similar expression profiles without performing global similarity 
calculations (which become prohibitive as datasets increase in size).   Hashing of L1000 data is the 
subject of ongoing work, and is not explored further here.  Nevertheless, it was found a model designed to 
facilitate hash-based lookup (i.e. having saturated, nearly binary internal representations), gave a higher 
validation set accuracy than other models tested, so this is the model that was used for downstream 
analyses.   
The model uses an input layer of 978 z-scores, followed by two hidden layers of 400 and 100 units, using 
a noisy sigmoid nonlinearity: 
 𝒚 = 𝝈�𝑾𝒙 + 𝒃 + 𝓝(𝟎, 0.25𝑰)� (1) 
 𝝈(𝒛) = (𝟏 + 𝑒−𝒛)−𝟏 (2) 
 
 Independent Gaussian noise with mean 0 and variance 0.25 (𝓝(𝟎, 0.25𝑰)), is added to the weighted sum 
of inputs plus bias (𝑾𝒙 + b) before applying sigmoid nonlinearity σ.  Noise was added to favor saturated 
(0/1) activations.  Dropout (Srivastava, Hinton et al. 2014) (p=0.5) and L1 weight decay (λ=10-5-10-6) are 
also used in hidden layers for regularization.  Finally, the cost layer uses a rectified loss function with a 
squared distance margin of 5:  
 𝑐 = 𝑠𝑜𝑓𝑡𝑝𝑙𝑢𝑠�1 − 𝑦(𝑚− 𝑑2)� (3) 
 𝑠𝑜𝑓𝑡𝑝𝑙𝑢𝑠(𝑥) = 𝑙𝑛(1 + 𝑒𝑥) (4) 
 
𝑦 = � 1 if pair are replicates    −1 if pair are non-replicates (5) 
 
     
Here c is the cost, m is the margin, y is the training target (-1 for non-replicate, +1 for replicate), d2 is the 
squared Euclidean distance between hidden vectors.  Theano (Bastien, Lamblin et al. 2012) automatic 
differentiation is used to backpropagate the cost to the model weights (including regularization) via the 
pylearn2 (Goodfellow, Warde-Farley et al. 2013) framework.  The model parameters are optimized using 
the RMSprop (Tieleman TH 2012) algorithm for adaptive minibatch stochastic gradient descent. 
After training the model, the weights were extracted and used to generate the activation state of the last 
hidden layer for each input sample.  While noise was added during training to regularize the model and 
encourage saturation, no noise was added during barcode generation in order to yield a deterministic 
transformation.  Perturbation barcodes are generated by thresholding activations of the last hidden layer to 
create a binary representation.    See ‘Availability of supporting material’ for software. 
Gene set enrichment analysis 
GSEA was conducted using 6034 gene sets derived from experimental gene signatures of up- and down-
regulated genes curated by Nextbio (Santa Clara, CA).  Enrichment was measured using a Wilcoxon test, 
and the resulting rank sum test z statistic was used as a score for a given gene set’s enrichment in a 
sample.  
LINCS consortium data 
Data downloaded from the NCBI GEO repository, accession GSE70138.  The file 
GSE70138_Broad_LINCS_Level4_ZSVCINF_mlr12k_n78980x22268_2015-06-30.gct.gz was 
downloaded in December 2015.  This dataset represents 273 compounds tested in 6-point dose response at 
two time points in 15 cell lines.  The level 4 (z-score vs. vehicle control) data was utilized. The first 978 
landmark (i.e. measured) gene measurements of the data matrix were analyzed.  In order to train the 
perturbation barcode model on the LINCS data, a subset of the data was selected: 10 and 1 µM treatments 
at 24 hours.  80% of the data was used for training, and 20% for validation, and the same hyperparameters 
were used for the model.  After the model was trained, the entire dataset was encoded with the 
perturbation barcodes learned from the training set.  Targets for 149 of the compounds were found to be 
annotated in Chembl (Gaulton, Bellis et al. 2012) or Metabase (Ekins, Bugrim et al. 2005) databases, only 
those targets affected with potencies <1µM were considered.  For each target, distances between profiles 
derived from distinct compounds sharing the target were compared to a sample not sharing the target via a 
t statistic.  Compound structures were clustered by hierarchical clustering of ECFP4 fingerprints, and 
gene expression profiles were clustered by the clara (Kaufman and Rousseeuw 2009) algorithm using 
cluster numbers (k) determined from optimal cuts of hierarchical clustering trees of samples of the 
datasets.  The clusterings were compared via the Adjusted Rand Index. 
Other analyses 
Crossvalidated support vector regression was performed with the caret package (Kuhn 2008), clustering, 
and correlation analyses were performed in R (Team 2012). 
For visualization, data, either z-scores or barcodes, were reduced to two dimensions using the t-
distributed stochastic neighbor embedding (t-SNE (Van der Maaten and Hinton 2008)) algorithm 
(implemented in tsne (Donaldson 2012) package for R).  Data was visualized by plotting the t-SNE 
features in Spotfire (Tibco). 
Compound structures were clustered using in-house fragment-based descriptors (Clark 2005), and 
hierarchical clustering with a threshold of Dice similarity>0.6.  Promiscuity was defined based on the 
frequency with which each compound was considered a ‘hit’ across HTS assays.  Project-specific hit 
calling was used for each assay. 
Known target annotation 
Merck’s chemogenomic database, the Chemical Genetic Interaction Enterprise (CHEMGENIE) was used 
to annotate compounds with their known targets.  CHEMGENIE contains harmonized data from external 
(e.g., ChEMBL, Metabase, and PDB) sources as well as internal sources (e.g., project team data, kinase 
profile panels, counterscreen panels, etc.) where compounds are represented as desalted InChIKeys and 
targets are represented with their Entrez Gene ID and/or UniProt Accession.  All target-based dose 
response data was added to each compound, and the highest affinity target was selected as a 
representative target for each compound.   
High Throughput Screening Fingerprints (HTS-FP) 
HTS fingerprints were constructed as described in the past (Petrone, Simms et al. 2012).  Briefly, the z-
scores of primary HTS screens at Merck were calculated for all screens where > 1e6 compounds had been 
screened (344 total screens).  The z-score for each screen was then stored as a vector for each compound.   
Any z-scores > 20 or <-20 was assigned a value of 20 or -20, respectively, so that artifactual values would 
not impact Pearson correlation calculations as significantly.  The Pearson correlation  of HTS-FPs was 
calculated between pairs of compounds by calculated the correlation of z-scores for assays that were in 
common between them (all other z-scores were ignored).  3471 compounds possessed HTS-FPs and were 
used in this analysis.  
Activity prediction 
t-SNE visualizations of z-scores representing the normalized L1000 data, and also of the 100-dimensional 
(nonthresholded) perturbation barcodes derived from the metric learning network were generated.  The 
locations of known EGFR/MEK/MAPK inhibitors on these maps were plotted, and points (i.e. 
representing compound treatments), that were surrounded by these known actives were selected for 
testing from each of the two maps.  Separately, in order to select actives from the full 978-dimensional z-
score or 100-dimensional barcode space, the ten nearest neighbors (by Euclidean distance) of each of the 
seed compounds were identified, and available compounds were tested for activity.  Compounds were 
tested in dose titration assay in 1536 well plate format using a previously optimized reporter gene assay.  
Cells (CellSensor ME-180 AP-1-bla, Life Technologies) were plated in the manufacturer’s recommended 
assay medium at 3000 cells/well in 9µl in black/clear tissue culture treated 1536 well plates (Greiner), and 
allowed to adhere overnight.  Compounds were added from DMSO serial dilution plates (50µM 
maximum assay concentration, 8-point, 3-fold dilutions), using a 50nl pintool (GNF Systems), and the 
cells incubated 30 min in a tissue culture incubator. The cells were then stimulated with Epidermal 
Growth Factor (EGF, Life Technologies) at 10ng/ml final concentration by adding 1µl 10x stock, and 
allowed to respond for 5 hours in a tissue culture incubator.  Beta-lactamase detection reagents 
(ToxBlazer, Life Technologies), were added per manufacturer’s instructions (2µl 6x mix), plates were 
incubated 2 hours at room temperature, and read using a bottom-reading multimode reader (Pherastar, 
BMG).  Data was normalized to no-stimulation (100% inhibition), and stimulation + DMSO (0% 
inhibition), controls, and percent inhibition was plotted along with logistic regression curve fits using 
Spotfire (Tibco).  Compounds were classified as active if they exceeded 50% inhibition of reporter 
activity without toxicity at concentrations below 10µM. 
 
Results & Discussion 
1. Transforming gene expression profiles 
We first introduce the data generation process and highlight the need for improved analyses.  The 
disparity between replicate profiles motivates the development of a metric learning approach that 
improves upon the current state of the art for this type of data analysis. 
High throughput expression profiling  
The experimental approach used in this work is depicted in Figure 1A.  Cells can be treated, lysed, and 
measured in medium throughput (384-well) formats.  The use of commodity consumables, reagents, and 
technology permits relatively low cost profiling of hundreds to thousands of compound-treated samples at 
a time (Peck, Crawford et al. 2006).  Reader intensity measurements are normalized using control samples 
and genes.  Next, each perturbation’s expression is compared to an internal (within-batch) negative 
control.  Twelve to sixteen vehicle (DMSO) controls are measured on each 384-well assay plate, and the 
expression of the remainder of samples is standardized to the average (median), and scale of variation 
(median absolute deviation), of these vehicle controls to yield robust z-scores, henceforth referred to as z-
scores for brevity.   
 
Figure 1.  Experimental setup and architecture of the deep model used.  A. Cells treated with compounds in 
384-well plates.  B. Cell lysate used for ligation mediated PCR with gene-specific probe pairs, and the gene 
expression measured using an optically addressed bead array technology.  C. Raw intensity is normalized 
and converted to relative expression changes versus control (z-scores) on a plate-wise basis.  Variability 
observed between biological replicates.   
 
Large scale gene expression profiling is known to have significant ‘batch’ effects that confound 
interpretation (Leek, Scharpf et al. 2010).  These effects are a result of differences in cell response from 
day to day.  The effects can be controlled for by performing replicate experiments, but the level of 
replication required to eliminate the batch effects is not practical for high throughput experimentation, 
which requires knowledge to be extracted from 1-2 replicates.  Additional approaches to reduce the 
influence of experimental batch include normalization of data within a batch such that all perturbations 
are compared to an internal negative control in the same batch.  In spite of measures to control batch 
effects, it is nevertheless observed that there is variability in cell response that makes it difficult to 
interpret data obtained on different days (Leek, Scharpf et al.).  As an example, for the dataset described 
below, we can assess the similarity of biological replicates’ gene expression profiles using Euclidean 
distance of the normalized expression changes versus control.  Looking at the similarity of each sample 
profile to every other in the dataset, the median rank of a sample’s biological replicate is approximately 
the 3rd percentile.  While this ranking can be considered an enrichment (versus a null hypothesis of ~50th 
percentile), the 3rd percentile in our dataset nevertheless implies that >200 treatment profiles are more 
similar to a given treatment than a sample that was treated identically on a different day. 
As mentioned above, the z-score data is confounded by batch effects that reduce the apparent similarity of 
expression responses deriving from identical treatments.  In order to improve on the performance of the z-
scores, another strategy that was explored is that of gene set enrichment analysis (GSEA, (Subramanian, 
Tamayo et al. 2005) ).  GSEA is a technique used to extract interpretable information from expression 
profiles, and is useful for placing the up- and down-regulation of genes into a biological context (e.g. 
biological pathway, disease state).  In addition, GSEA profiles (i.e. enrichment scores of a sample across 
many different gene sets), can be thought of as a means of averaging, and potentially making more robust, 
the expression profiles by using biological context as a prior.  Thus, it might be expected (Edelman, 
Porrello et al. 2006) that GSEA profiles might be more reproducible, and more predictive, than raw 
expression data.  Indeed, when one looks at the correlation of pairs of samples treated with the same 
compound, one sees that GSEA profiles show higher concordance than z-score profiles day-to-day and 
cell-to-cell (Supplementary Figure 1).  In the previoiusly mentioned measure of average rank of 
replicates, GSEA yields a median rank of ~1%, with ~70 profiles more similar to a given sample than its 
biological replicate. 
Deep metric learning 
Since there is room for improvement over both of the previously described methods, we sought to 
evaluate alternate strategies to increase the sensitivity and specificity of interpretations and predictions  
derived from  relatively large data sets that we are currently  generating on the L1000 platform.  In 
particular, as a first step, we sought to increase the concordance of samples that should exhibit the same 
phenotypic response, while separating them from those that should be distinct.  Using the similarity of 
biological replicates as a gold standard, the goal was to recast the data in a way that maximizes the 
similarity of replicates in contrast to non-replicate samples.  This can be thought of as a metric learning 
problem, whereby one learns a new measure of distance or similarity between points, one that 
distinguished replicates from non-replicates.  Initial experimentation with linear and kernel methods 
(Bellet, Habrard et al. 2013) failed to yield significant improvements over the raw data, thus deep neural 
network models were next evaluated.   
Deep learning is an extension of decades-old artificial neural networks, and has recently shown 
impressive performance on a number of image and speech recognition tasks (Hinton, Deng et al. 2012, 
Krizhevsky, Sutskever et al. 2012).   As the properties and capabilities of these models have begun to be 
elucidated, it is becoming more feasible and reproducible to create highly accurate multilayer neural 
network models.  In addition, advances in model design have  been complemented by increased 
computational power and larger datasets that enable the training of comprehensive, expressive models, 
whose generalization performance is facilitated by regularization (Bengio 2012, Bengio 2013).  In 
addition to providing a flexible model that is able to fit complicated datasets, deep networks have the 
additional advantage of learning a hierarchical representation of the data, whereby lower layers of the 
model learn to represent the fine-grained detail of the input data, and higher layers represent increasing 
layers of abstraction.  Thus, inspecting the higher layers of a model has the potential of revealing the 
underlying high-level structure of the data, with reduced sensitivity to noise and contextual details.  We 
thus explored a multilayered network with the dual goal of developing a suitable distance metric, and also 
developing a robust data representation for downstream analyses. 
Most machine learning methods consider a single input sample at a time, though each sample is generally 
represented by multiple variables, or features.  The goal of this effort was to learn not about individual 
samples, but about the comparison of pairs of inputs in order to learn a new metric that better captures 
what is known about the data.  Thus, a method was chosen that permits comparative learning in a neural 
network framework.  We implemented a version of a siamese neural network (Liu 2013, Hu, Lu et al. 
2014) to perform metric learning on a dataset of L1000 data (Figure 2).   
 
Figure 2. A:  Metric learning network: a pair of 978-element z-score vectors is input to the network as 
adjacent vectors.  Data is transformed through two layers (400 followed by 100 units), of nonlinearities 
(noisy sigmoid activation functions).  The activations of the second hidden layer (H2(x1) and H2(x2)) are 
combined in the cost layer by calculating a Euclidean distance between the two representations.  The 
margin cost is calculated based on the -1/1 (non-replicate/replicate indicator) target and the squared 
distance.  B.   Once the model is trained, expression profiles are converted to barcodes by passing them 
through the first two (now noisless sigmoid) hidden layers and thresholding the activation of the second 
hidden layer to yield perturbation barcodes. 
 
A number of model architecture properties (also known as hyperparameters) need to be set prior to the 
optimization of model weights of a neural network by gradient descent.  These include number of layers, 
layer sizes, activations of layers, regularization types and weights, and cost type and any parameters.  We 
undertook a greedy manual search of hyperparemters, optimizing the validation set accuracy for 
predicting replicate vs. nonreplicate pairs.  Among over 60 models tested, we settled on the architecture 
described below since it provided the best performance on validation data.  
The final model that emerged from optimization of the neural network architecture performs the 
following: a pair of 978-dimensional z-score vectors representing two different expression profiles is 
given to the network as input, the data is transformed by two layers of noisy sigmoid layers, and then the 
representations of the members of the pair are compared to each other by calculating a Euclidean 
distance.  A margin loss is calculated based on the distance versus the known target status of the pair (i.e. 
replicates or not replicates).  The cost is used to train the network via backpropagation of the cost 
gradients (Rumelhart, Hinton et al. 1988).  While siamese networks have been previously depicted as a 
linked pair of networks transforming the pair of inputs for comparison (see (Liu 2013, Hu, Lu et al. 
2014)), in practice we found it simpler to implement the siamese network model as a single network that 
processes pairs of samples as adjacent inputs (Figure 2).  In this architecture, the paired input is provided 
as two consecutive vectors to one network that processes the elements of the pair through the 
aforementioned hidden layers and then calculates the cost.   
The network was trained on 80% of the compounds, using a validation held-out set of 10% to select 
model architecture and detailed configuration (hyperparameters), and a final test set of 10% was used to 
estimate generalization performance of the selected model.  The trained model was able to correctly 
categorize 97% of test pairs as replicates/non-replicates (F1 = 0.87, (Van Rijsbergen 1979) ).  The deep 
model performed significantly better than a linear metric learning model (a single hidden layer model 
with linear activation function, otherwise same as deep network), which achieves 74% accuracy (F1 = 
0.47).  As a baseline, a model that randomly samples from the empirical distribution of replicates/non-
replicates would have an accuracy of 56% (F1 = 0.33). 
Having demonstrated that it is possible to recast the data in a way that captures the similarity of 
identically treated samples, we set out to determine if the learned model can be used to improve 
interpretability of large scale expression profiling campaigns.  Since the model can separate replicates 
from nonreplicates, and since the model output is a function of a simple Euclidean distance calculated on 
the internal representation (hidden layer activations), we reasoned that this internal representation 
captures the discriminatory power learned by the model.  We explored whether this internal 
representation has additional useful properties, as for example do the internal word representations of 
skip-gram language models (Mikolov, Chen et al. 2013).  The internal representation was extracted from 
the learned model by using the activation of 100-dimensional second hidden layer as the learned feature 
vector of each data point (Figure 2B).  This representation is a short, fixed-length, almost binary 
representation that captures expression profile changes.  In order to facilitate computation of similarities 
and hash-based lookup, the almost-binary representation (~95% of activations >0.9 or < 0.1), was 
thresholded to be exactly binary (i.e. values ≥ 0.5 were set to 1, rest to 0).  This binary representation of 
cellular gene expression profile changes in response to treatments is referred to as a ‘perturbation 
barcode.’ 
Thus the model yields a new encoding of the original data, a representation that was designed only to 
increase the similarity of biological replicates relative to non-replicates.  Information is necessarily lost in 
reducing 978-dimensional continuous data to 100-dimensional binary representations.  The question that 
remains is whether biologically interesting aspects of the data are retained in the simplified encoding.   
Thus, we evaluated whether the model described herein learns useful, generalizable aspects related to 
compound effects on cells as a byproduct of learning to identify replicates.  The perturbation barcodes 
were assessed for their ability to identify similarities between compounds in a variety of contexts (Table 
1).  Furthermore, we directly compared the performance of the barcodes to the minimally processed z-
score data and the gene set enrichment score profiles.   
The median rank (out of 7573) of each sample’s biological replicate is shown in Table 1.  For each 
sample, the similarity of all other samples’ profiles is ranked, and the median rank across samples of the 
biological replicate is reported.  For the z-score data this value is 225, indicating that, on average, there 
are 223 profiles more similar to a given sample (itself ranked #1), than the sample’s biological replicate.  
The median rank for GSEA score data is 72, and for perturbation barcodes it is 24.  The result on the 
perturbation barcodes demonstrates that the training objective was met: samples that are replicates are 
more similar under the features derived from the metric learning than they are in the original data space. 
metric z-score GSEA perturbation barcode 
Median rank of replicates (of 7573) 225 72 24 
Distance by shared target, t statistic -1 -38 -43 
Structural clustering overlap with expression clustering 0.01 0.03 0.17 
Correlation of HTS profiles with expression 0.04 0.02 0.12 
Promiscuity prediction by SVR, R2 0.21 0.16 0.34 
 
Table 1.  Performance of learned perturbation barcodes compared to z-scores  and GSEA scores.  Row 1: 
For each sample with replicates in the dataset, profiles are ranked based on Euclidean distances calculated 
from the various representations, and the median value of the replicates’ ranks across samples is reported.  
Row 2:  Distance of pairs of profiles of compounds that share a target annotation compared to those that do 
not.  Significance of difference in mean distance measured with a t statistic. For reference, a permutation 
analysis of the target labels in the barcode dataset yielded a minimum t statistic of -5.8 from 100 random 
permutations (p<0.01). Row 3: Compounds clustered based on structure and on the expression profiles they 
induce.  The overlap of the structural and expression clustering is measured by the Adjusted Rand Index on 
a 0-1 scale.  For reference, a permutation analysis of the cluster labels in the barcode dataset yielded a 
maximum ARI of 0.002 from 100 random permutations (p<0.01).  Row 4: Similarity of phenotypic profiles 
measured either by activity across HTS assays, or by induced expression changes.  The correlation of each 
expression measure to the HTS fingerprint data is shown.  For reference, a permutation analysis of the 
sample labels in the barcode dataset yielded a maximum correlation of 0.001 from 100 random 
permutations (p<0.01). Row 5:  A support vector regression model was trained using the various 
expression features to predict compound promiscuity (fraction HTS screens in which a compound is 
active).   Crossvalidation performance is measured using R2 of predicted vs. observed promiscuity.  The 
standard error of barcode R2 values was 0.06 (p<0.01). 
 2. Comparison of Perturbation Barcode with State of the Art  
Next, one might ask whether a model trained to recognize samples treated with the same compound 
would also retain additional relationships related to biological function and chemical similarity.  In order 
to avoid re-discovering the similarity of replicates, for this and subsequent comparisons, replicates were 
resolved to a single representation by averaging the hidden layer 2 activations of the replicate samples 
before thresholding to barcodes, and analogously, z-scores and GSEA results represent the average of 
replicates.   
We tested the ability of the different representations to recognize different compounds targeting the same 
cellular factor as having similar profiles.  Due to compound-specific polypharmacologies, one shouldn’t 
expect any pair of distinct compounds to have identical profiles, but one should expect compounds 
sharing a target to have profiles that are more similar, on average, than pairs of compounds not sharing a 
molecular target.  We looked at those compounds for which target annotation was available (1297 
compounds having annotated targets modulated with potency < 1µM), and asked if compounds that share 
a target are more similar to each other in induced gene expression profiles than compounds that do not.  
Using a t statistic for the difference of mean distances of shared versus unshared targets, the comparison 
on the z-score data is not significant, with a t statistic of -1.  The GSEA-summarized data is more 
significant with t~-38, while the barcode data shows the highest preferential similarity of profiles of 
compounds sharing a target annotation: t~-43.  This indicates that the latter two methods are able to 
encode the expression profiles of compounds in a way that emphasizes biological similarity. 
A well-studied approach to categorize compounds is by similarity of chemical structure, with one 
underlying assumption being that similarity of structure is related to similarity in function.  Thus 
molecules are clustered using descriptors designed to allow molecules considered similar by a trained 
chemist to be grouped together, to the exclusion of dissimilar molecules (Brown and Martin 1996).  
Analogously, expression profiles can be clustered to find sets of genes or of samples that are more similar 
to each other than to other instances, in an attempt to identify cohesive functional groupings (Alizadeh, 
Eisen et al. 2000).  One might expect a significant but imperfect overlap between compound structural 
clusters and those derived from expression profiling.  The expectation of significant overlap comes from 
the fact that compounds with shared scaffolds or similarly arranged functional groups would be more 
likely to target the same cellular factors and thus yield similar expression profiles.  Imperfect overlap 
would be expected because small changes in structure can lead to significant changes in activity, a 
phenomenon studied in structure-activity relationships of chemical series (Stumpfe and Bajorath 2012).  
In order to compare overlap of structure and phenotype, a comparison of the clusterings of the two types 
of data was performed.  Compound structures were clustered using hierarchical clustering of fragment-
based descriptors with a minimum similarity criterion to define clusters.  Expression data was clustered 
using hierarchical clustering followed by a dynamic tree cutting (Langfelder, Zhang et al. 2008) approach 
to generate discrete, well separated-clusters.  The overlap of clusterings is measured with the Adjusted 
Rand Index (Hubert and Arabie 1985) which varies from 1.0 for perfect overlap, to 0 for overlap expected 
by chance.  The z-score data shows little overlap of expression clustering with the structural clusters (1%, 
Table 1), and the GSEA-based clusters modesty better (3%). In contrast, the perturbation barcode clusters 
have significantly higher overlap with structural clusters than z-scores (17%).  These results are not 
sensitive to the clustering algorithm nor to compound structural descriptors, as similar observations were 
obtained with affinity propagation clustering and atom pair descriptors (Sheridan, Miller et al. 1996) (not 
shown). 
Next we set out to determine whether the barcode reveals insight into biological function. In order to 
compare two different measures of biological activity, the profile of 3471 compounds across multiple 
High Throughput Screens (HTS) was compared to the L1000 expression profiles.  The activity profiles 
across HTS assays could be thought of a biological fingerprint, as it represents the activity of the 
compound in a multitude of disparate assays, both cell-based and biochemical.  Such profiles do not 
evenly span all potential biological responses since they opportunistically derived, depending on the 
history of each compound and the organization performing the HTS campaigns.  However, in some ways 
the HTS profiles are more relevant to drug discovery since many of the constituent assays directly 
measure the molecular activities of interest rather than induced transcriptional programs.  The correlation 
matrix of HTS fingerprints (HTS-FP, (Petrone, Simms et al. 2012)) of the compounds was compared to 
the correlation matrices of z-scores, GSEA scores, and perturbation barcodes.  The correlation of the 
triangular correlation matrices (Mantel statistic) was used as a measure of how similar the HTS activity 
profiles are to z-score, GSEA, and perturbation barcodes.  The perturbation barcodes show more than 
three times the similarity to HTS profiles compared the other two scores (Table 1). 
Finally, it was of interest to explore if there is a difference in the ability of the three data representations 
to predict a high-level property of compounds, namely their promiscuity.  The promiscuity of a compound 
is defined here as the fraction of the HTS assays in which the compound was scored as active, ranging 
from 0 to 0.5 in our dataset (median 0.04, 3836 compounds with data).  Promiscuity of compounds is of 
interest in drug discovery, wherein modulators that are both potent and specific (i.e. non-promiscuous) are 
generally sought.   One way to ascertain if promiscuity information is present in the different expression 
profile representations is to assess the ability of each representation to generate a model that can 
quantitatively predict this property for samples not in the training set.  Predictive support vector 
regression models were trained on each data representation, and the average cross-validation coefficient 
of determination (R2) was used as measure of the ability of the models to predict properties of compounds 
on the basis of the profiling data (Table 1).  Given that the perturbation barcodes are derived solely from 
the z-score data, and that they are in some ways a more impoverished representation of the original data 
(978 dimensional real values to 100-dimensional binary values), it was surprising to find that models 
trained on the barcodes are able to explain ~60% more promiscuity compared to the z-scores. 
To test whether the feature mapping can be applied to other datasets, we trained an identical model 
architecture on a sample of L1000 data generated by the LINCS consortium (Duan, Flynn et al. 2014).  
For the comparisons we could make, we found the same benefits of the perturbation barcode versus the 
raw data.  Table 2 shows that the learned barcode brought biological replicates closer to each other 
(median in top 1% most similar profiles versus top 27% for z scores).  Furthermore, average profiles of 
distinct compounds sharing a target are significantly closer to each other in the perturbation barcode space 
than in the original space:  for each annotated target of compounds in the dataset, the distances of 
compounds sharing versus not sharing the target were compared via a t-statistic, and the mean of these 
statistics was found to be non-significantly higher (+1) for the z-score data but significantly smaller (-37) 
for the barcodes (Table 2).  Finally, although this dataset contained a relatively small number of 
structurally distinct compounds, we could still detect a greater than 2-fold increase in correspondence 
between clustering of transcriptional profiles and structural descriptors in the perturbation barcodes versus 
the z-scores (Table 2). 
metric z-score perturbation barcode 
Median rank of replicates (of 79890) 21496 649 
Distance by shared target, mean t statistic 1 -37 
Structural clustering overlap with expression clustering 0.004 0.010 
 
Table 2 
 
3. Prospective Activity prediction 
In order to compare the ability of the learned features to capture the biological activity of tested 
perturbations in an exploratory setting, the predictive ability of the perturbation barcodes was tested.   We 
compared the ability of the perturbation barcodes and z-scores to retrieve molecules with similar targets 
in both a two-dimensional visualization, and by nearest neighbor searches in the respective native data 
spaces.  t-SNE (Van der Maaten and Hinton 2008) is a dimensionality reduction technique used for 
visualization in large datasets.  The transformation provided by t-SNE is not quantitative and does not 
preserve all aspects of the original data space, but in a 100-1000-dimensional data space, t-SNE is the best 
system we have found for exploring such data sets.  The predictive fidelity of the t-SNE map derived 
from expression z-scores was compared to that of a t-SNE map derived from the perturbation barcodes in 
order to ascertain how much information one can hope to glean by studying the visualization of a large 
dataset (Figure 3A - C).  This use case was studied because it is representative of a common query one 
may want to pose of a dataset: given knowledge about the molecular mechanism of action of some 
compounds, can we expect compounds nearby to them in a visualization to share similar mechanisms?  
Three known inhibitors of the EGF/MAPK pathway that were tightly clustered in both maps were chosen 
as seeds, and 31 unknown compounds found nearby the known MAPK pathway actives in either or both 
t-SNE maps were tested for their ability to block signaling from EGF to AP1 using a reporter gene assay.  
The compounds selected in this way were structurally diverse, with only two of the compounds sharing 
the same structural cluster. Figure 3E shows that there were two unknown compounds that were identified 
in the z-score  t-SNE maps and were confirmed to be active in MAPK signaling.  By comparison, the 
barcode map revealed the same two and four additional novel unknowns (Figure 3F).  Negative control 
compounds selected to be far away from the MAPK tools in both maps showed no specific AP-1 reporter 
activity (Supplementary figure 2).  One compound that was a known pathway inhibitor did not confirm in 
this assay as it showed high potency (IC50~35nM), but low efficacy (Emax~41%), thus not meeting the 
activity threshold.  The additional actives discovered only in the barcode map demonstrate that the 
visualization derived from the barcodes has increased sensitivity to capture biological activities versus the 
raw data-derived visualization.  Significantly, none of the newly identified AP-1 reporter inhibitors were 
structurally similar to the known actives (Dice similarity less than 0.6). 
 Figure 3.  Visualizations of the data based on z-scores or perturbation barcodes were examined to select 
candidate compounds in the phenotypic neighborhood of a series of known MAPK pathway inhibitors.  A - 
D:  t-SNE maps of the data, z-scores on top,  perturbation barcode maps on the bottom.  A, B: the entire 
dataset is shown with the tested compounds in dark blue.  C,D:  The neighborhood of the query MAPK 
pathway inhibitor compounds (orange) is shown.  Common MAPK tools used for nearest neighbor analysis 
are circled.  E,F:  Results of AP-1 reporter assays.  Known MAPK actives are distinguished from 
unknowns predicted to be active in C,D.  G,H:  Rather than selecting neighbors of seed MAPK tool 
compounds in the t-SNE map, nearest neighbors in the native datasets were selected and tested in the AP-1 
reporter assay.  Key as in E,F.  See supplementary figure 2 for breakdown by categories, including 
overlaps. 
 
Finally, we looked at the neighborhood of the same known MAPK actives in the original data space for 
both the z-scores (978-dimensional) and the barcodes (100-dimensional) rather than the reduced 2-
dimensional t-SNE space.  Nearest neighbors were chosen by Euclidean distance and tested in the reporter 
assay as above. Figure 3G & 3H show that a larger number and fraction of unknowns identified as 
candidates from the barcode data were confirmed to have AP-1 reporter activity compared to the z-scores.   
 
Conclusions 
We present here a straightforward way to extract features from gene expression data that are in many 
ways more expressive and robust than the original gene expression changes.  While training of a deep 
network is a somewhat specialized process, once an adequate model is trained, additional samples can 
efficiently be converted to perturbation barcodes with no (or little), further optimization needed, as 
evidenced by the simple transfer of the model to external (LINCS) data.   
Others have proposed novel methods for analyzing L1000 data.  In particular, Liu et al (Liu, Su et al. 
2015) presented a pipeline that incorporates raw intensity processing and gene assignment through gene 
set enrichment and production of features informed by protein interaction data.  While this type of 
biological annotation is potentially useful, our proposed perturbation barcode is self-contained, and does 
not rely on noisy and incomplete biological databases for utility.  In addition, the improvements in 
performance of the learned features compares favorably with other approaches used in the field, including 
GSEA.  Finally, it was shown that the perturbation barcodes can be used to meaningfully predict pathway 
modulation activity of compounds prospectively.  This ability is of value in uncovering unknown modes 
of action (either primary or secondary) of compounds of interest, and the fact that it can be read directly 
from a visualization, shows the potential of the approach to simplify and enhance hypothesis generation 
from big data. 
We demonstrate that similarity in the barcode space is indicative of more similarity in compound target 
and compound structure, activity across biological assays, and predictivity of biological action.  
Furthermore, the somewhat unexpected observation that models of general compound properties like 
promiscuity can be better built using the learned features than the data that the features were learned from, 
indicates that there are positive side effects of the compressive data encoding.  We attribute this 
phenomenon to the denoising property of the learned features, or equivalently, extraction of robust 
underlying biological factors from the corrupted versions observed in experimentation (due to 
measurement error, batch effects, and stochastic variation in response).   
We anticipate that elaborations of approaches such as this one will be fruitful for other applications in 
biological and chemical domains, as they have been in artificial intelligence. A more ambitious goal of 
algorithmic design of molecules may be based on the combination of phenotypic information, quantitative 
structure-activity relationships, and pharmacokinetic/pharmacodynamic models with generative models 
for chemical structures.  In the meantime, the direct application of the described metric learning-based 
representation technique to other high volume, high dimensional data has the potential to significantly 
reduce the effects of noise and to improve interpretability and the quality of generated hypotheses. 
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 Supplementary Figures 
 
Supplementary Figure 1.  Correlation of profiles of samples treated with the same compound and dose on 
different days A, or in different cell types B.  The red line indicates z-scores of gene expression changes, 
and the black line indicates gene set enrichment scores derived from the z-scores and a library of 
experimentally derived gene sets.  The distribution is smoothed using a Gaussian kernel density estimate. 
 
Supplementary Figure 2.  Activity prediction results. A, candidates selected based on t-SNE maps of z-
scores, barcodes, or both, are shown along with activity in the EGF/AP1 reporter assay. B, candidates 
selected based on the native datasets (978-dimensional) z-scores, (100-dimensional) barcodes,  or both, are 
shown along with the observed activity in the EGF/AP1 reporter assay.  
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